Khutaija Noor, MBBS, FCR If you are looking into a clinical trial for a condition like depression, the paperwork can feel like a riddle. The researchers say they need people who are currently struggling with symptoms, but then they ask: " Is your heart healthy? Are your kidneys working well? Have you stayed out of the hospital lately? " It feels like a contradiction. You might think, " I’m here because I’m not okay- so why do I need to be 'stable' in everything else ?" After

We are thrilled to congratulate our Lead Coordinator, Khutaija Noor, MBBS, FCR , on her recent publication in STAT's First Opinion column! Her insights were featured in an important article discussing the evolving landscape of psychiatric drug development and emerging novel therapies. We’re proud to have her on the Amicis team and excited to see her continue to succeed! Please take a moment to check out her published work: https://www.statnews.com/2025/11/14/psychiatric-drug-

Khutaija Noor, MBBS, FCR For years, many people saw clinical trials as a desperate "last resort," something only considered when all standard treatments for therapeutic illnesses had failed. That outdated perception is rapidly changing. Today, more individuals across the United States are exploring clinical trials much earlier in their health journey. They're seeking not just access to new therapies, but also the enhanced care and deep engagement that come with the research p